Granules India's Virginia Facility Achieves Flawless USFDA Inspection

Entertainment National Sports Markets Business & Economy Lifestyle World Astrology & Religion Technology Education & Jobs Auto Politics Viral Opinions

Loading more articles...

Granules India's Virginia Facility Aces USFDA Inspection with Zero Observations

Granules India's Virginia Facility Aces USFDA Inspection with Zero Observations

C

CNBC TV18•05-03-2026, 12:50

Granules India's Virginia Facility Aces USFDA Inspection with Zero Observations

•Granules India's US-based step-down subsidiary's Virginia packaging facility received an Establishment Inspection Report (EIR) with No Action Indicated (NAI) status from USFDA.
•The inspection of Granules Consumer Health LLC's Manassas, Virginia facility occurred between December 1 and December 3, 2025.
•This marks the facility's second consecutive USFDA inspection with zero observations, following a similar outcome in March 2023.
•The facility serves as a packaging and distribution hub for OTC and prescription medicines, processing controlled substances.
•Chairman Krishna Prasad Chigurupati stated the outcome reflects the company's focus on quality, safety, and regulatory compliance.

Read Full Article on Cnbc in English

✦

More like this

✦

More like this

Virginia Appeals Ruling Blocking Law Limiting Kids' Social Media to One Hour Daily

Representational image (Image: News18)

Himachal declares snakebite poisoning a notifiable disease

Representational image (Image: News18)

Lupin's Goa Plant Receives Satisfactory EIR from USFDA

Aurobindo Pharma's Apitoria Unit Gets USFDA VAI Classification, Inspection Closed

Aurobindo Pharma's Apitoria Unit Gets USFDA VAI Classification, Inspection Closed

Representational image (Image: News18)

FCI: Region-wise PDS diversion data 'not traceable' at HQ; CIC issues notice

NEET-PG Cut-Off Reduction: Centre Assures Supreme Court No Compromise on Standards

NEET-PG Cut-Off Reduction: Centre Assures Supreme Court No Compromise on Standards